NEKTAR THERAPEUTICS (NKTR) › Net IncomeNEKTAR THERAPEUTICS (NKTR) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$102.52M2010: -$37.94M2011: -$133.98M2012: -$171.85M2013: -$162.01M2014: -$53.92M2015: -$81.18M2016: -$153.52M2017: -$96.69M2018: $681.31M2019: -$440.67M2020: -$444.44M2021: -$523.84M2022: -$368.20M2023: -$276.06M2024: -$118.96M2025: -$164.08M-$164.08M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$164.08M-37.9%2024-$118.96M+56.9%2023-$276.06M+25.0%2022-$368.20M+29.7%2021-$523.84M-17.9%2020-$444.44M-0.9%2019-$440.67M-164.7%2018$681.31M+804.6%2017-$96.69M+37.0%2016-$153.52M-89.1%2015-$81.18M-50.6%2014-$53.92M+66.7%2013-$162.01M+5.7%2012-$171.85M-28.3%2011-$133.98M-253.1%2010-$37.94M+63.0%2009-$102.52M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share